Lilly(Eli) (LLY) Earnings (2008 - 2026)
Lilly(Eli) (LLY) earnings from Jun 30, 2008 to Mar 31, 2026. The TTM Lilly(Eli) (LLY) earnings is $25B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Lilly(Eli) (LLY) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +127.60% |
| 3 Years TTM | +64.42% |
| 5 Years TTM | +32.92% |
| 10 Years TTM | +26.98% |
| All Time TTM | +16.33% |
Annual Earnings change of Lilly(Eli) (LLY)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $7.40B | -64.17% |
| 2025 | $21B | +94.90% |
| 2024 | $11B | +102.10% |
| 2023 | $5.24B | -16.09% |
| 2022 | $6.24B | +11.88% |
| 2021 | $5.58B | -9.88% |
| 2020 | $6.19B | -25.54% |
| 2019 | $8.32B | +157.38% |
| 2018 | $3.23B | -1683.54% |
| 2017 | -$204M | -126.44% |
| 2016 | $772M | -67.95% |
| 2015 | $2.41B | +0.75% |
| 2014 | $2.39B | -48.97% |
| 2013 | $4.68B | +14.58% |
| 2012 | $4.09B | -5.96% |
| 2011 | $4.35B | -14.24% |
| 2010 | $5.07B | +17.11% |
| 2009 | $4.33B | -308.93% |
| 2008 | -$2.07B | -170.16% |
| 2007 | $2.95B | N/A |
Comparison Lilly(Eli) (LLY) five years earnings CAGR with competitors
Lilly(Eli) (LLY) five years earnings CAGR is 32.92%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 98.24% | +198.44% |
| NVO | Novo Nordisk | 23.10% | -29.81% |
| AZN | Astrazeneca plc | 21.17% | -35.68% |
| NVS | Novartis AG | 11.21% | -65.94% |
| JNJ | Johnson & Johnson | 6.84% | -79.23% |
| MRK | Merck & Co Inc | 4.92% | -85.05% |
| GSK | GSK Plc | 2.84% | -91.36% |
| AMGN | AMGEN Inc | 1.94% | -94.10% |